Pharmacia Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Summary of Product Characteristics last updated on the eMC: 09/11/2009
SPC Depo-Medrone 40mg/ml

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 09/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01-Oct-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 4.8: There has been an amendment to the clinical data.
Updated on 17/04/2008 and displayed until 09/11/2009
Reasons for adding or updating:
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01-Mar-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



4.4 – Addition of warning of potential psychiatric side-effects occurring with systemic steroids.

4.8 – Addition of psychiatric side-effects that have been reported with corticosteroids.

Updated on 18/09/2007 and displayed until 17/04/2008
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
Date of revision of text on the SPC:   05/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7 - changed Sanwich to sandwich
Updated on 11/09/2007 and displayed until 18/09/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   05/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

7.1 – Change to the MAH address

10 – change in the date of revision

Updated on 25/03/2003 and displayed until 11/09/2007
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MA number
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
Updated on 24/08/2001 and displayed until 25/03/2003
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 28/08/2001 and displayed until 24/08/2001
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/07/2001 and displayed until 28/08/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 27/04/2001 and displayed until 18/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 22/09/2000 and displayed until 27/04/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   methylprednisolone acetate